ATE126221T1 - Thiazolidinverbindeungen, deren herstellung und therapeutische verwendung. - Google Patents

Thiazolidinverbindeungen, deren herstellung und therapeutische verwendung.

Info

Publication number
ATE126221T1
ATE126221T1 AT92311813T AT92311813T ATE126221T1 AT E126221 T1 ATE126221 T1 AT E126221T1 AT 92311813 T AT92311813 T AT 92311813T AT 92311813 T AT92311813 T AT 92311813T AT E126221 T1 ATE126221 T1 AT E126221T1
Authority
AT
Austria
Prior art keywords
alkyl
hydrogen
preparation
therapeutic use
optionally substituted
Prior art date
Application number
AT92311813T
Other languages
German (de)
English (en)
Inventor
Takao Yoshioka
Takahide Nishi
Tsutomu Kanai
Yuichi Aizawa
Kunio Wada
Takashi Fujita
Hiroyoshi Horikoshi
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Application granted granted Critical
Publication of ATE126221T1 publication Critical patent/ATE126221T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT92311813T 1991-12-26 1992-12-24 Thiazolidinverbindeungen, deren herstellung und therapeutische verwendung. ATE126221T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP34457191 1991-12-26

Publications (1)

Publication Number Publication Date
ATE126221T1 true ATE126221T1 (de) 1995-08-15

Family

ID=18370304

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92311813T ATE126221T1 (de) 1991-12-26 1992-12-24 Thiazolidinverbindeungen, deren herstellung und therapeutische verwendung.

Country Status (21)

Country Link
EP (1) EP0549365B1 (enExample)
JP (1) JP2833949B2 (enExample)
CN (1) CN1032751C (enExample)
AT (1) ATE126221T1 (enExample)
AU (1) AU654223B2 (enExample)
CA (1) CA2086277A1 (enExample)
CZ (1) CZ389792A3 (enExample)
DE (1) DE69204041T2 (enExample)
DK (1) DK0549365T3 (enExample)
ES (1) ES2078671T3 (enExample)
FI (1) FI925849A7 (enExample)
GR (1) GR3017632T3 (enExample)
HK (1) HK196095A (enExample)
HU (1) HU215450B (enExample)
IL (1) IL104238A (enExample)
MX (1) MX9207595A (enExample)
NO (1) NO302471B1 (enExample)
NZ (1) NZ245612A (enExample)
RU (1) RU2095354C1 (enExample)
TW (1) TW211007B (enExample)
ZA (1) ZA9210021B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO302519B1 (no) * 1991-12-26 1998-03-16 Sankyo Co Tiazolidinforbindelser som inneholder en kinongruppe, og farmasöytisk preparat
CA2146701A1 (en) * 1994-04-11 1995-10-12 Takashi Fujita Heterocyclic compounds having anti-diabetic activity, their preparation and their use
EP0783888A1 (en) 1995-12-26 1997-07-16 Sankyo Company Limited Use of troglitazone and related thiazolidinediones in the manufacture of a medicament for the treatment and prophylaxis of osteoporosis
US6331633B1 (en) * 1998-05-08 2001-12-18 Calyx Therapeutics Inc. Heterocyclic analogs of diphenylethylene compounds
DE19828113A1 (de) * 1998-06-24 2000-01-05 Probiodrug Ges Fuer Arzneim Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV
DE19828114A1 (de) * 1998-06-24 2000-01-27 Probiodrug Ges Fuer Arzneim Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV
DE19926233C1 (de) * 1999-06-10 2000-10-19 Probiodrug Ges Fuer Arzneim Verfahren zur Herstellung von Thiazolidin
US6620830B2 (en) 2000-04-21 2003-09-16 Pfizer, Inc. Thyroid receptor ligands
DE60115132T2 (de) * 2000-04-21 2006-07-06 Pfizer Products Inc., Groton Thyroid-Rezeptorliganden
US6680387B2 (en) 2000-04-24 2004-01-20 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
US6768008B2 (en) 2000-04-24 2004-07-27 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
CA2402123A1 (en) * 2000-04-24 2001-11-01 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
JP2003040877A (ja) * 2001-07-24 2003-02-13 Sumika Fine Chemicals Co Ltd ５−［６−（２−フルオロベンジルオキシ）−２−ナフチル］メチル−２，４−チアゾリジンジオンの製造方法及びその精製方法
NZ571870A (en) 2006-03-16 2011-07-29 Metabolic Solutions Dev Co Thiazolidinedione analogues for the treatment of hypertension and for lowering lipids
AU2007227581B2 (en) 2006-03-16 2012-11-08 Metabolic Solutions Development Company, Llc Thiazolidinedione analogues for the treatment of metabolic inflammation mediated disease
WO2009038681A1 (en) * 2007-09-14 2009-03-26 Metabolic Solutions Development Company Thiazolidinedione analogues for the treatment of hypertension
US8304441B2 (en) 2007-09-14 2012-11-06 Metabolic Solutions Development Company, Llc Thiazolidinedione analogues for the treatment of metabolic diseases
NZ600390A (en) 2009-12-15 2013-08-30 Metabolic Solutions Dev Co Llc Ppar-sparing thiazolidinedione salts for the treatment of metabolic diseases
MX2012012092A (es) * 2010-04-19 2012-12-17 Metabolic Solutions Dev Co Llc Sintesis novedosa para compuestos de tiazolidinadiona.
AU2011242844A1 (en) * 2010-04-21 2012-11-01 Metabolic Solutions Development Company, Llc Thiazolidinedione analogues
NZ606574A (en) 2010-08-10 2015-02-27 Metabolic Solutions Dev Co Llc Novel synthesis for thiazolidinedione compounds
CN115433144B (zh) * 2022-10-09 2023-09-19 燃点(南京)生物医药科技有限公司 一种脂肪酸酯类化合物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US5143930A (en) * 1990-02-07 1992-09-01 Sankyo Company, Limited Thiazolidine derivatives with anti-diabetic activity, their preparation and their use
NO302519B1 (no) * 1991-12-26 1998-03-16 Sankyo Co Tiazolidinforbindelser som inneholder en kinongruppe, og farmasöytisk preparat

Also Published As

Publication number Publication date
RU2095354C1 (ru) 1997-11-10
DE69204041D1 (de) 1995-09-14
FI925849A7 (fi) 1993-06-27
CN1032751C (zh) 1996-09-11
AU654223B2 (en) 1994-10-27
FI925849A0 (fi) 1992-12-23
MX9207595A (es) 1994-06-30
AU3043192A (en) 1993-07-01
GR3017632T3 (en) 1996-01-31
IL104238A (en) 1996-10-31
HU9204130D0 (en) 1993-04-28
ZA9210021B (en) 1993-07-02
CA2086277A1 (en) 1993-06-27
EP0549365A1 (en) 1993-06-30
NO302471B1 (no) 1998-03-09
JP2833949B2 (ja) 1998-12-09
CN1074680A (zh) 1993-07-28
DK0549365T3 (da) 1995-12-18
DE69204041T2 (de) 1996-03-28
NZ245612A (en) 1994-06-27
HU215450B (hu) 1999-04-28
EP0549365B1 (en) 1995-08-09
NO924964L (no) 1993-06-28
HK196095A (en) 1996-01-05
ES2078671T3 (es) 1995-12-16
CZ389792A3 (en) 1994-01-19
JPH05239041A (ja) 1993-09-17
NO924964D0 (no) 1992-12-22
TW211007B (enExample) 1993-08-11
HUT67788A (en) 1995-04-28

Similar Documents

Publication Publication Date Title
ATE126221T1 (de) Thiazolidinverbindeungen, deren herstellung und therapeutische verwendung.
AU589795B2 (en) New 5-alkoxy-2,4-diamino-alkyl benzols, and hair tinting means using them
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
ATE165092T1 (de) Thiazolidinederivate, die eine quinone-gruppe enthalten, ihre herstellung und therapeutische anwendung
RU92016231A (ru) Тиазолидиновые соединения, способ их получения, фармацевтическая композиция и способ лечения
ES557664A0 (es) Un procedimiento para la sintesis de derivados de imidazol.
ATE97899T1 (de) 1,8-benzonaphthyridinderivate, ihre herstellung und diese enthaltende zusammensetzungen.
ATE59844T1 (de) Indolcarboxamidderivate, ihre salze, verfahren und zwischenprodukte, anwendung als heilmittel und zusammensetzungen die sie enthalten.
NZ246598A (en) Trazodone derivatives; compounds and preparation, pharmaceutical compositions; intermediate compounds
ATE124686T1 (de) Phenylalkylamine und diese enthaltende fungizide.
FI890187A0 (fi) Foerfarande foer framstaellning av hydroxialkylerande foereningar, saolunda erhaollna nya foereningar och deras anvaendning.
ATE98961T1 (de) 1,8-benzonaphthyridinderivate und ihre herstellung.
DE69005318D1 (de) 1,8-Benzonaphthyridinderivate, ihre Herstellung und diese enthaltende Zusammensetzungen.
GR3008034T3 (enExample)
DE59003446D1 (de) 13-Brom und 13, 14-Dibrom-Ergoline, ihre Herstellung und Verwendung in Arzneimitteln.
ES2044883T3 (es) Procedimiento para preparar quinoxalinas sustituidas.
DE69112095D1 (de) 1-Phenoxycarbonyl-2-Pyrrolidon-Derivate und nootrope Wirkstoffe.
ATE98232T1 (de) 0-(1,2,4-triazolyl-1)-0-phenyl-acetale und diese enthaltende fungizide.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee